BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 27932442)

  • 1. Contraceptive sales in the setting of the Zika virus epidemic.
    Bahamondes L; Ali M; Monteiro I; Fernandes A
    Hum Reprod; 2017 Jan; 32(1):88-93. PubMed ID: 27932442
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stagnant contraceptive sales after the Zika epidemic in Brazil.
    Bahamondes L; Ali M; Monteiro I; Fernandes A
    Eur J Contracept Reprod Health Care; 2017 Oct; 22(5):381-383. PubMed ID: 29166843
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Estimated disability-adjusted life years averted by long-term provision of long acting contraceptive methods in a Brazilian clinic.
    Bahamondes L; Bottura BF; Bahamondes MV; Gonçalves MP; Correia VM; Espejo-Arce X; Sousa MH; Monteiro I; Fernandes A
    Hum Reprod; 2014 Oct; 29(10):2163-70. PubMed ID: 25085802
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized clinical trial of the effect of intensive versus non-intensive counselling on discontinuation rates due to bleeding disturbances of three long-acting reversible contraceptives.
    Modesto W; Bahamondes MV; Bahamondes L
    Hum Reprod; 2014 Jul; 29(7):1393-9. PubMed ID: 24812309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of contraceptive sales before and during the COVID-19 pandemic in Brazil.
    Charles CM; Munezero A; Bahamondes LG; Pacagnella RC
    Eur J Contracept Reprod Health Care; 2022 Apr; 27(2):115-120. PubMed ID: 35156489
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Canadian Contraception Consensus (Part 2 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N
    J Obstet Gynaecol Can; 2015 Nov; 37(11):1033-9. PubMed ID: 26629725
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Canadian Contraception Consensus (Part 1 of 4).
    Black A; Guilbert E; ; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman WV; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; ; Ferguson C; Fortin C; Kielly M; Mansouri S; Todd N;
    J Obstet Gynaecol Can; 2015 Oct; 37(10):936-42. PubMed ID: 26606712
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of vaginal administration of misoprostol before intrauterine contraceptive insertion following previous insertion failure: a double blind RCT.
    Bahamondes MV; Espejo-Arce X; Bahamondes L
    Hum Reprod; 2015 Aug; 30(8):1861-6. PubMed ID: 26040478
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 3-year multicentre randomized controlled trial of etonogestrel- and levonorgestrel-releasing contraceptive implants, with non-randomized matched copper-intrauterine device controls.
    Bahamondes L; Brache V; Meirik O; Ali M; Habib N; Landoulsi S;
    Hum Reprod; 2015 Nov; 30(11):2527-38. PubMed ID: 26409014
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Zika Contraception Access Network: a feasibility programme to increase access to contraception in Puerto Rico during the 2016-17 Zika virus outbreak.
    Lathrop E; Romero L; Hurst S; Bracero N; Zapata LB; Frey MT; Rivera MI; Berry-Bibee EN; Honein MA; Monroe J; Jamieson DJ
    Lancet Public Health; 2018 Feb; 3(2):e91-e99. PubMed ID: 29371100
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The use of long-acting reversible contraceptives in Latin America and the Caribbean: current landscape and recommendations.
    Bahamondes L; Villarroel C; Frías Guzmán N; Oizerovich S; Velázquez-Ramírez N; Monteiro I
    Hum Reprod Open; 2018; 2018(1):hox030. PubMed ID: 30895242
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A prospective, open-label, single arm, multicentre study to evaluate efficacy, safety and acceptability of pericoital oral contraception using levonorgestrel 1.5 mg.
    Festin MP; Bahamondes L; Nguyen TM; Habib N; Thamkhantho M; Singh K; Gosavi A; Bartfai G; Bito T; Bahamondes MV; Kapp N
    Hum Reprod; 2016 Mar; 31(3):530-40. PubMed ID: 26830816
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fertility decision-making during the Zika virus epidemic in Brazil: Where is the decision?
    Stolow J; Kendall C; Marto Leal Pinheiro F; Campos da Rocha Feitosa M; Alves de Almeida Furtado K; Ferreira Martins A; Paz Albino Dos Santos M; Ecilda Lima Ellery A; Dias L; Cristina de Holanda Barreto I; Moses L; Castro A; Dunn C; Kerr L
    Sex Reprod Healthc; 2022 Jun; 32():100722. PubMed ID: 35381437
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Contraceptive Use Among Nonpregnant and Postpartum Women at Risk for Unintended Pregnancy, and Female High School Students, in the Context of Zika Preparedness - United States, 2011-2013 and 2015.
    Boulet SL; D'Angelo DV; Morrow B; Zapata L; Berry-Bibee E; Rivera M; Ellington S; Romero L; Lathrop E; Frey M; Williams T; Goldberg H; Warner L; Harrison L; Cox S; Pazol K; Barfield W; Jamieson DJ; Honein MA; Kroelinger CD
    MMWR Morb Mortal Wkly Rep; 2016 Aug; 65(30):780-7. PubMed ID: 27490117
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Canadian Contraception Consensus (Part 3 of 4): Chapter 7--Intrauterine Contraception.
    Black A; Guilbert E; Costescu D; Dunn S; Fisher W; Kives S; Mirosh M; Norman W; Pymar H; Reid R; Roy G; Varto H; Waddington A; Wagner MS; Whelan AM; Mansouri S
    J Obstet Gynaecol Can; 2016 Feb; 38(2):182-222. PubMed ID: 27032746
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Information on advances in sciences and technology. Advances in contraceptive technology].
    Andrade AT
    Bol Cent Biol Reprod; 1993; 12(1):51-2. PubMed ID: 12345521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hormonal and intrauterine methods for contraception for women aged 25 years and younger.
    Krashin J; Tang JH; Mody S; Lopez LM
    Cochrane Database Syst Rev; 2015 Aug; 2015(8):CD009805. PubMed ID: 26280888
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The cost-effectiveness of long-acting reversible contraceptive methods in the UK: analysis based on a decision-analytic model developed for a National Institute for Health and Clinical Excellence (NICE) clinical practice guideline.
    Mavranezouli I;
    Hum Reprod; 2008 Jun; 23(6):1338-45. PubMed ID: 18372257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Historical survey of modern reversible contraceptive methods].
    Mbabajende V
    Imbonezamuryango; 1986 Apr; (5):14-7. PubMed ID: 12268230
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.